Leveraging Medical Analytics to Improve Strategy, Launch, Outcomes and Care Models

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
KEY FINDINGS
VIEW TOC AND LIST OF EXHIBITS

High-impact Medical Affairs organizations are harnessing the potential of advanced analytics to address critical unmet needs, redefine strategies, optimize product launches, and enhance patient outcomes and care models. However, the pace of advancement remains uneven among competitors, due in many cases to resource constraints, regulatory uncertainty, or lack of technical expertise in expanding Medical Analytics capabilities.

Best Practices, LLC undertook this benchmarking research to explore how Medical Affairs groups are growing the use of analytics, gaining organizational support for higher investment, and achieving strategic goals by means of both big and small data analysis. This report will serve as a reference point for Medical Affairs leaders to unlock the full potential of Medical Analytics and propel their organization to new heights in better strategy, enhanced care models and improved outcomes which support unmet needs.

Video Brief:

Industries Profiled:
Health Care; Biotech; Biopharmaceutical; Pharmaceutical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Communications; Science

Companies Profiled:
Acadia Healthcare; Amicus Therapeutics; Apellis Pharmaceuticals; ASC Therapeutics; Astellas; AstraZeneca; Baxter International; Bayer; Biogen; bioMerieux; Boehringer Ingelheim; Daiichi Sankyo; Domp�; Eisai; Eli Lilly and Company; Envista; GE Healthcare; Grifols; Janssen; Kyowa Kirin; Merck Sharp & Dohme; Merz Aesthetics; Myovant Sciences; Nobel Biocare; Novartis; Novo Nordisk; Organon; Roche; Sumitomo Pharma; Sunovion; Symbiotix; Teva Pharmaceutical Industries Ltd; Thermo Fisher Scientific; Unilab; Varian; Xeris Pharmaceuticals

Study Snapshot

Best Practices, LLC engaged 41 Medical Affairs leaders from 38 leading biopharma organizations. A range of functional leaders were targeted to capture the diverse strategies and analytical needs across the industry. Functions represented by this study include: Medical Operations, Medical Excellence, Digital & Medical Analytics, HEOR, Field Medical, Medical Communications, Medical Info, Strategic Insights, and other Senior Medical Leadership. Best Practices LLC also conducted deep-dive interviews with Medical Affairs & Analytics leaders at 9 organizations to capture additional insights.

Key topics covered in this report include:

Organizational Goals of Using Medical Analytics
Current Uses of Medical Analytics to Support Key Activities
Big vs. Small Data Utilization
Key Data Sources and Impact
Average Maturity of Analytics Support for Medical Affairs
Justifying Investment for Increased Resources
Sources of Medical Analytics Expertise
Effective Structure of Medical Analytics Groups
Staffing and Resourcing

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

Organizational Goals for Medical Analytics: Biopharma manufacturers are seeking to maximize Medical impact through insights generation (81%), enhanced customer interactions (63%), and omnichannel engagement (51%) fueled by a strategic Medical Analytics capability.

Advancing Adoption: 85% of companies believe Medical Analytics can accelerate adoption and care model change but picking the right pilot is an art.

Table of Contents

Sr. No.	Topic	Slide No.
I.	Executive Summary	Pg. 3-13
II.	Leveraging Analytics in Medical Affairs	Pg. 14-22
III.	Growth Areas for Medical Analytics	Pg. 23-30
IV.	Next Steps for Building a Successful Medical Analytics Capability	Pg. 31-37
V.	Key Insights & Lessons Learned	Pg. 38-42
VI.	Participant Demographics	Pg. 43-45
VII.	About Best Practices, LLC	Pg. 46

List of Charts & Exhibits

I. Executive Summary

Benchmark study partner companies
One-page research summary
One-page FAQ for leaders to address commonly asked questions about growing analytics capabilities within Medical Affairs
Data summary
Data strategy
SWOT assessment
Key lessons learned
Analytics KPIs

II. Leveraging Analytics in Medical Affairs

Hierarchy of analytics: Types and impact of analytics with examples
Small vs. big data sets
Top organizational goals for Medical Analytics
Key data sources used by Medical organizations
Case successes: Impact and efficiency driven by Analytics on 3 critical fronts
Data strategy

III. Growth Areas for Medical Analytics

Current maturity of Analytics for external engagement
Current maturity of Analytics for enhanced Medical value
Analytics maturity curve
Current maturity of Analytics: Internal activities and resourcing activities
Tips and considerations for accelerating adoption and care model change
Advancing adoption
Uses of AI in post-ChatGPT world

IV. Next Steps for Building a Successful Medical Analytics Capability

Hallmarks of maturity of Medical Analytics groups
Bridging the gap
Structure and staffing of Medical Analytics groups
Launching Medical Analytics
Justifying Medical Analytics investment

V. Key Insights & Lessons Learned

FAQ checklist for Medical Analytics leadership teams
Full SWOT assessment
Key lessons learned
Analytics KPIs

VI. Participant Demographics

Therapeutic areas represented by benchmark companies
Geographic responsibilities of benchmark partners

Leveraging Medical Analytics to Improve Strategy, Launch, Outcomes and Care Models

ID: POP-369

Features:

Pages: 46

Published: 2023

Delivery Format: Shipped

Video Brief:

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6A5087207494EFA8100258A2B00528F76
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/leveraging-medical-analytics-to-improve-strategy-launch-outcomes-care-models?opendocument
18
19opendocument
2018.97.14.91
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR